Share

EUROPE "Endocrine therapy or partial irradiation of the breast as exclusive postoperative treatment in women aged =70 years with early-stage luminal-A type breast cancer: randomized non-inferiority phase 3 study"

Project objectives

This is a multicenter randomized phase 3 study which therefore aims to measure the quality of life through the use of the QLQ-C30 questionnaire and the QLQ-BR45 and ELD-14 modules in patients aged ≥70 years with breast cancer in initial luminal A stage undergoing breast-conserving surgery and exclusive partial breast radiotherapy or exclusive endocrine therapy.

Start and end date

March 23, 2021 - In progress

Project Manager

Sara Ramella - Principal Investigator

Coordinating institution of the project

Oncological Radiotherapy, University of Florence

Other Institutions involved

  • 20 national and 2 international satellite centers
QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right